Article content

Vancouver, British Columbia, Oct. 23, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) announces that it has granted an aggregate 3,143 stock options, exercisable at $0.70 per share and valid for a term of three years, and an aggregate 239,000 restricted share units, valid for a term between three to five years, to an officer of the Company and to consultants and employees of the Company’s subsidiary.  The stock options and restricted share units are issued pursuant to the Company’s share compensation plans and all restricted share units and stock options are subject to vesting over up to one year. All securities are subject to a hold period of four months and one day in accordance with applicable securities laws and policies of the Canadian Securities Exchange.

Article content

Article content

About Rocket Doctor AI Inc.

Article content

Article content

Article content

Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Article content

Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs to provide care to more than 800,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices – improving efficiency, restoring autonomy to MDs, and expanding patient access to care.

Article content

By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare – making it more scalable, equitable, and patient-centered.

Article content

Article content

To learn more about Rocket Doctor AI Inc’s products and services, contact:

Article content

Article content

Article content

Article content

Cautionary Statements

Article content

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the granting of stock options and restricted share units to consultants, the terms and vesting conditions of such stock options and restricted share units, and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.’s expectations include the risk that the stock options or restricted share units may not vest on the anticipated terms, risks related to the Company’s share compensation plan, and other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.